Recent Quotes (30 days)

You have no recent quotes
chg | %

Microbix Biosystems Inc  

(Public, TSE:MBX)   Watch this stock  
Find more results for MBX
0.000 (0.00%)
Mar 27 - Close
TSE data delayed by 15 mins - Disclaimer
Currency in CAD
Range 0.25 - 0.25
52 week 0.18 - 0.34
Open 0.25
Vol / Avg. 0.00/22,823.00
Mkt cap 21.18M
P/E     -
Div/yield     -
EPS -0.03
Shares 84.70M
Beta -1.75
Inst. own     -
Feb 14, 2017
Q1 2017 Microbix Biosystems Inc Earnings Release (Estimated)

Key stats and ratios

Q4 (Dec '16) 2016
Net profit margin -164.74% 7.86%
Operating margin -172.42% 1.56%
EBITD margin - 12.28%
Return on average assets -51.47% 3.07%
Return on average equity -84.40% 5.17%
Employees 20 -
CDP Score - -


265 Watline Ave
+1-905-3618910 (Phone)
+1-905-3618911 (Fax)

Website links


Microbix Biosystems Inc. is a life science company and manufacturer of viral and bacterial antigens and reagents for the diagnostics industry. The Company develops biological products and technologies. The Company operates in two segments: the development, manufacturing and distribution of cell-based products and technology, and the provision of facility, technical and production personnel for contract research and development. The Company's Virology Products (Virology) business manufactures and sells cell culture-based biological products. The Company's pipeline of technologies and products include Kinlytic, which is a thrombolytic drug with various applications, including the treatment of life-threatening blood clots, and LumiSort, which is a semen sexing technology for the livestock industries. It operates in three geographical areas, including North America, Europe and in other foreign countries. It owns and operates a Virology manufacturing facility at Mississauga, Ontario.

Officers and directors

William J. Gastle Executive Chairman of the Board
Vaughn C. Embro-Pantalony President, Chief Executive Officer, Director
Jim Currie Chief Financial Officer
Age: 58
Peter M. Blecher Independent Director
Mark A. Cochran Independent Director
Cameron L Groome Independent Director
Martin A. Marino Independent Director
Joseph D. Renner Independent Director